Cyclotron and Radiochemistry Facility

research

Facility Description

The Cyclotron and Radiochemistry Facility is a joint venture with Memorial Sloan-Kettering Cancer Center and is essential to the continued widespread utilization and scientific development of PET in that it will produce various positron-emitting radiolabeled pharmaceutical drugs designed and engineered to complement the pharmacokinetics of the clinical molecular target. The preparation of these unique drugs requires a source of radionuclide (such as 11C or 18F) and the tools for subsequent synthesis of the drug incorporating the radionuclide. The cyclotron produces 19.2 MeV protons and 9.5 MeV deuterons in two separate beam lines.